ArticleTherapeutic advances in gastroenterology2025
Monthly intravenous maintenance treatment with ustekinumab regains clinical response in patients with Crohn's disease who no longer respond to the drug when administered subcutaneously.
Berta López-Sáez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.